Cite
HARVARD Citation
Chen, G. et al. (2023). Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study. Lancet gastroenterology and hepatology. pp. 422-431. [Online].